100 Participants Needed

Health Communication Tool + SDoH Screening for Lung Cancer

FV
Overseen ByFrancis Valenzona
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Hackensack Meridian Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

A multilevel lung screening intervention that pairs Social Determinants of Health (SDoH) screening and referral with a tailored health communication and decision support tool for lung screening has the potential to significantly impact lung screening uptake among at-risk individuals in the community, particularly among those who face barriers related to SDoH. In addition, findings will advance the understanding of effective strategies for improving lung screening and prevention efforts in non-traditional settings, with the ultimate goal of reducing the burden of lung cancer. As ways to support the realization of the public health benefit of lung cancer screening are considered, multiple strategies and venues to reach, and intervene, with screening-eligible is key. The goal of this study is to compare the effectiveness of a community-based lung screening educational tool paired with a social determinants of health (SDoH) screening assessment and referral process compared to a community-based lung cancer screening (LCS) educational tool alone as part of community outreach activities to improve (a) LCS rates (primary outcome); (b) intention to screen; and (c) individual-level potential drivers of LCS (health literacy, mistrust, stigma, fatalism, knowledge, health beliefs). It is hypothesized that providing SDoH screening and referral will result in higher levels of LCS, forward movement of intention to screen, and improved individual-level drivers of LCS.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Health Communication Tool + SDoH Screening for Lung Cancer?

Research shows that community-based educational interventions, like the Lung AIR program, can effectively increase knowledge and intention to complete lung cancer screening, especially when delivered one-on-one. Additionally, understanding social factors like income and geographic location can help tailor interventions to improve screening rates.12345

Is the Health Communication Tool + SDoH Screening for Lung Cancer safe for humans?

The research articles do not provide specific safety data for the Health Communication Tool + SDoH Screening for Lung Cancer, but they discuss the importance of informed decision-making and communication about risks and benefits in lung cancer screening.56789

How does the Health Communication Tool + SDoH Screening for Lung Cancer treatment differ from other treatments for lung cancer?

This treatment is unique because it combines community-based lung cancer screening with a focus on social determinants of health (SDoH), which are factors like income and access to healthcare that can affect a person's health. It aims to improve lung cancer screening rates by addressing these broader social factors and using a health communication tool to engage patients.2371011

Research Team

LC

Lisa Carter-Bawa, PhD

Principal Investigator

Hackensack Meridian Health

Eligibility Criteria

This trial is for individuals aged 50-80 who can consent, currently smoke or quit within the last 15 years, have a history of significant smoking (20 pack-years), and have never had lung cancer screening. They must speak and understand English. Those with previous lung screenings or diagnosed with lung cancer are excluded.

Inclusion Criteria

I am between 50 and 80 years old.
Able to provide informed consent
You currently smoke or quit smoking within the past 15 years.
See 3 more

Exclusion Criteria

You have previously had a lung cancer screening scan.
I have been diagnosed with lung cancer.
Unable to speak and understand English

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Intervention

Participants receive a community-based lung cancer screening educational tool, with or without a social determinants of health screening assessment and referral process

1 day
1 visit (in-person)

Follow-up

Participants are monitored for lung cancer screening uptake and changes in individual-level drivers of lung cancer screening

3 months

Treatment Details

Interventions

  • Current practice - Community-based lung cancer screening (LungTalk)
  • Social determinants of health screening assessment and referral process
Trial Overview The study tests if adding a Social Determinants of Health (SDoH) assessment and referral process to a community-based educational tool improves lung cancer screening rates compared to just the educational tool alone in at-risk communities.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Social determinants of health screeningExperimental Treatment2 Interventions
Participants will receive a social determinants of health screening assessment and referral process in addition to the community-based lung cancer screening educational tool.
Group II: Community-based lung cancer screeningActive Control1 Intervention
Participants will receive a community-based lung cancer screening educational tool.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Hackensack Meridian Health

Lead Sponsor

Trials
141
Recruited
42,900+

Becton, Dickinson and Company

Industry Sponsor

Trials
80
Recruited
92,000+

Tom Polen

Becton, Dickinson and Company

Chief Executive Officer since 2020

Bachelor’s degree from Salisbury University, MBA from Johns Hopkins University

Meera Gopalakrishnan

Becton, Dickinson and Company

Chief Medical Officer

Ph.D. in Biomedical Engineering from the University of Memphis

Findings from Research

A study of 438 individuals in Indiana revealed that sociodemographic factors such as race, geographic location, income, and health insurance significantly influence lung cancer screening behavior.
The research identified disparities in screening participation based on race and residence, highlighting the need for targeted outreach and educational programs to improve screening rates among underrepresented groups.
Understanding lung cancer screening behavior: Racial, gender, and geographic differences among Indiana long-term smokers.Carter-Harris, L., Slaven, JE., Monahan, PO., et al.[2023]
The Lung AIR intervention effectively increased knowledge and reduced fear about lung cancer screening among 292 participants, demonstrating its feasibility as a community-based educational program.
One-on-one phone sessions were particularly effective, leading to greater increases in participants' intention to complete screening compared to in-person group sessions, especially among those with lower income and higher smoking rates.
Adapting Community Educational Programs During the COVID-19 Pandemic: Comparing the Feasibility and Efficacy of a Lung Cancer Screening Educational Intervention by Mode of Delivery.Bouchard, EG., Saad-Harfouche, FG., Clark, N., et al.[2023]
Out of 2,797 patients with scheduled lung cancer screening appointments, 32.7% of appointments were missed, highlighting a significant issue with adherence to screening protocols.
Social determinants of health, such as being self-reported Black or having Medicaid insurance, were linked to higher odds of missing appointments, indicating that targeted interventions are needed to address these disparities and improve access to lung cancer screening.
The Impact of Social Determinants of Health on Lung Cancer Screening Utilization.Shin, D., Fishman, MDC., Ngo, M., et al.[2023]

References

Understanding lung cancer screening behavior: Racial, gender, and geographic differences among Indiana long-term smokers. [2023]
Adapting Community Educational Programs During the COVID-19 Pandemic: Comparing the Feasibility and Efficacy of a Lung Cancer Screening Educational Intervention by Mode of Delivery. [2023]
The Impact of Social Determinants of Health on Lung Cancer Screening Utilization. [2023]
Using Community Health Advisors to Increase Lung Cancer Screening Awareness in the Black Belt: a Pilot Study. [2023]
A Multilevel Approach to Investigate Relationships Between Healthcare Resources and Lung Cancer. [2023]
Barriers and facilitators for low-dose computed tomography lung cancer screening in rural populations in the United States: a scoping review protocol. [2023]
Identifying Community Perspectives for a Lung Cancer Screening Awareness Campaign in Appalachia Kentucky: The Terminate Lung Cancer (TLC) Study. [2018]
Results from Lung Cancer Screening Outreach Utilizing a Mobile CT Scanner in an Urban Area. [2023]
Acceptability of a standalone written leaflet for the National Health Service for England Targeted Lung Health Check Programme: A concurrent, think-aloud study. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Advancing health equity in cancer care: The lived experiences of poverty and access to lung cancer screening. [2021]
11.United Statespubmed.ncbi.nlm.nih.gov
Lung Cancer Screening Outreach Program in an Urban Native American Clinic. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security